*Some Market data delayed by 15 mins.

Ascendis Pharma A/S American Depositary Shares

Symbol: ASND (NASDAQ)
202.88 ▲ (0.95%) 1.910

Company Description:
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Key Stats
  • Today's Open: $202.32
  • Today's High: $205.27
  • Today's Low: $198.14
  • Today's Volume: 224.87K
  • Yesterday Close: $200.97
  • Yesterday High: $204.125
  • Yesterday Low: $199.99
  • Yesterday Volume: 399.87K
  • Last Min Volume: 20
  • Last Min High: $202.88
  • Last Min Low: $202.88
  • Last Min VWAP: $202.88
Company Profile
  • Name: Ascendis Pharma A/S American Depositary Shares
  • Website: https://www.ascendispharma.com
  • Listed Date: 2015-01-28
  • Location: ,
  • Market Status: Active
  • CIK Number: 0001612042
  • SIC Code:
  • SIC description:
  • Market Cap: $12.17B
  • Round Lot: 100
  • Outstanding Shares: 60.55M
  • Asset Type: ADRC
RECENT FILINGS FOR ASND
Filing Date Filing Type Format
2025-09-30 6-K View
2025-09-10 6-K View
2025-09-09 144 View
2025-08-29 144 View
2025-08-27 144 View
2025-08-20 144 View
2025-08-15 144 View
2025-08-14 144 View
2025-08-14 SCHEDULE 13G/A View
2025-08-14 SCHEDULE 13G/A View
2025-08-13 144 View
2025-08-13 144 View
2025-08-13 6-K View
2025-08-13 SCHEDULE 13G View
2025-08-12 144 View
2025-08-07 6-K View
2025-08-07 6-K View
2025-07-28 6-K View
2025-07-09 6-K View
2025-06-27 6-K View

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.